Literature DB >> 16895696

[Prevalence of hepatitis C, hepatitis B and HIV infection among haemodialysis patients in Ibn-Rochd university hospital, Casablanca].

Kawtar Boulaajaj1, Younes Elomari, Bouchra Elmaliki, Bouchra Madkouri, Driss Zaid, Noufissa Benchemsi.   

Abstract

The viral infections are frequent in haemodialysis patients, notably those due to the hepatitis C virus (HCV), the hepatitis B virus (HBV) and the human immunodeficiency virus (HIV). The objective of this study is to determine the prevalence of the hepatitis C, the hepatitis B, the HIV infection in haemodialysis patients and the main risk factors for hepatitis C in the chronic haemodialysis patients treated in haemodialysis unit of Ibn Rochd University Hospital in Casablanca. This retrospective study was performed in 186 chronic haemodialysis patients and showed a high prevalence of HVC infection (76%), the prevalence of HBV infection was at 2%, none of the patients had detectable antibodies of HIV. Among the patients infected by the HCV, the mean duration of dialysis was 8,7 years. The mean number of blood units transfused was 16,5. Seventeen patients (11%) had no history of blood transfusion. In conclusion, the blood transfusion is not considered to be a like a major risk factor of the HCV infection in haemodialysis patients and this since the systematic detection of the anti-HCV antibodies in the blood donors. The nosocomial transmission of HCV seems to be the main risk factor HCV infection in the haemodialysis units requiring a strict adherence to infection control procedures for prevention of HVC infection in haemodialysis patients.

Entities:  

Mesh:

Year:  2005        PMID: 16895696     DOI: 10.1016/j.nephro.2005.06.012

Source DB:  PubMed          Journal:  Nephrol Ther        ISSN: 1769-7255            Impact factor:   0.722


  17 in total

1.  Incidence and prevalence of hepatitis B and hepatitis C viruses in hemodialysis patients in Lebanon.

Authors:  Antoine Abou Rached; Lara El Khoury; Talal El Imad; Abdallah S Geara; Josette Jreijiry; Walid Ammar
Journal:  World J Nephrol       Date:  2016-01-06

Review 2.  Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker.

Authors:  Yousra A Mohamoud; F DeWolfe Miller; Laith J Abu-Raddad
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 3.  Hepatitis C virus infection in the Middle East and North Africa "MENA" region: injecting drug users (IDUs) is an under-investigated population.

Authors:  S Ramia; N M Melhem; K Kreidieh
Journal:  Infection       Date:  2012-01-12       Impact factor: 3.553

4.  Improving hepatitis B vaccine efficacy in end-stage renal diseases patients and role of adjuvants.

Authors:  Mohammad Hossein Somi; Babak Hajipour
Journal:  ISRN Gastroenterol       Date:  2012-09-18

5.  Prevalence and risk factors of hepatitis B and C viruses among haemodialysis patients in Gaza strip, Palestine.

Authors:  Abed El-kader Y El-Ottol; Abdelraouf A Elmanama; Basim M Ayesh
Journal:  Virol J       Date:  2010-09-01       Impact factor: 4.099

6.  Viral hepatitis a to e in South mediterranean countries.

Authors:  Sanaa M Kamal; Sara Mahmoud; Tamer Hafez; Runia El-Fouly
Journal:  Mediterr J Hematol Infect Dis       Date:  2010-02-10       Impact factor: 2.576

7.  Hepatitis C and hepatitis B seroprevalence and associated risk factors in hemodialysis patients in Guilan province, north of Iran: HCV and HBV seroprevalence in hemodialysis patients.

Authors:  Farahnaz Joukar; Sepiedeh Besharati; Hasan Mirpour; Fariborz Mansour-Ghanaei
Journal:  Hepat Mon       Date:  2011-03       Impact factor: 0.660

Review 8.  The epidemiology of hepatitis C virus in the Maghreb region: systematic review and meta-analyses.

Authors:  Fatima A Fadlalla; Yousra A Mohamoud; Ghina R Mumtaz; Laith J Abu-Raddad
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

9.  Hepatitis B and C infection in haemodialysis patients in Libya: prevalence, incidence and risk factors.

Authors:  Wiam A Alashek; Christopher W McIntyre; Maarten W Taal
Journal:  BMC Infect Dis       Date:  2012-10-20       Impact factor: 3.090

10.  Hepatitis B and C in dialysis units in Kosova.

Authors:  Skender Telaku; Hajrullah Fejza; Ymer Elezi; Teuta Bicaj
Journal:  Virol J       Date:  2009-06-04       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.